News

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

INDUSTRY NEWS

Back to the future: From target-selective drug design to AI-enabled polypharmacology

May 20, 2024
Read More
INDUSTRY NEWS

The Christopher and Dana Reeve Foundation Announces #3.1M Spinal Cord Injury Research Grants

March 6, 2024
Read More
INDUSTRY NEWS

Emyria teams with CRO PsychoGenics for MDMA-like Drug Development

September 21, 2022
Read More
INDUSTRY NEWS

Overcoming Mental Health’s Drug Development Challenges with AI

August 23, 2022
Read More
INDUSTRY NEWS

Industrializing Behavioral Testing to Redefine Neuropsychiatric Drug Discovery

August 17, 2022
Read More
INDUSTRY NEWS

We Need a New Prozac: The Demand for Brain Drug Innovation

August 15, 2022
Read More
INDUSTRY NEWS

Mental Health Champions: Why & How Dr. Emer Leahy of PsychoGenics Is Helping To Champion Mental Wellness

August 14, 2022
Read More
INDUSTRY NEWS

The CNS Drug Development Drum Beat is Getting Louder

August 5, 2022
Read More
INDUSTRY NEWS

GBR Connect Series – Interview with Emer Leahy, PsychoGenics

March 15, 2022
Read More